Cardiovascular Therapeutics

雜志介紹

Cardiovascular Therapeutics雜志介紹

《Cardiovascular Therapeutics》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱心血管治療，本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.4，最新CiteScore 指數(shù)為5.6。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Effect of Mini-Tyrosyl-tRNA Synthetase/Mini-Tryptophanyl-tRNA Synthetase on Angiogenesis in Rhesus Monkeys after Acute Myocardial Infarction.

  Author: Zeng R, Wang M, You GY, Yue RZ, Chen YC, Zeng Z, Liu R, Qiang O, Zhang L.

• Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

  Author: Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.

• Bioinformatics Analyses of Differentially Expressed Genes Associated with Acute Myocardial Infarction.

  Author: Gao Y, Qi GX, Guo L, Sun YX.

• Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.

  Author: Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ.

英文介紹

Cardiovascular Therapeutics雜志英文介紹

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.

Subject areas include (but are by no means limited to):

Acute coronary syndrome

Arrhythmias

Atherosclerosis

Basic cardiac electrophysiology

Cardiac catheterization

Cardiac remodeling

Coagulation and thrombosis

Diabetic cardiovascular disease

Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)

Hyperlipidemia

Hypertension

Ischemic heart disease

Vascular biology

Ventricular assist devices

Molecular cardio-biology

Myocardial regeneration

Lipoprotein metabolism

Radial artery access

Percutaneous coronary intervention

Transcatheter aortic and mitral valve replacement.